Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02263495
Brief Title: Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer (EG_PG)

First Submitted : October 6, 2014
First Submitted that Met QC Criteria : October 10, 2014
First Posted : October 13, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : July 12, 2020
Last Update Posted : July 14, 2020